Healthcare

Is Abbott’s Dissolving Stent Set to Transform Peripheral Artery Disease Treatment in Europe?

Key Highlights A Breakthrough in PAD TreatmentAbbott has received CE Mark approval in Europe for its Esprit™ BTK…

ByByAnuja SinghSep 7, 2025

Could the Medtronic–Abbott Partnership Shift the Future of Diabetes Technology as FDA Clears MiniMed™ 780G for Broader Use?

Key Highlights Expanding Integration Through Abbott PartnershipThe U.S. FDA has cleared Medtronic’s SmartGuard™ algorithm as an interoperable automated…

ByByAnuja SinghSep 7, 2025

Can AI-Powered Platforms from Certara, Recursion, and Charles River Cut Drug Development Timelines by 50% as FDA Pushes Beyond Animal Testing?

Key Takeaways FDA’s New Roadmap Sparks Industry Transformation The U.S. FDA has outlined a bold strategy to make…

ByByAnuja SinghSep 6, 2025

Could Johnson & Johnson’s 99.7% Acute Success in VARIPURE Substudy Redefine the Global Pulsed Field Ablation Market?

Key Highlights Breakthrough Clinical Data from ESC 2025Johnson & Johnson MedTech unveiled results from the VARIPURE substudy of…

ByByAnuja SinghSep 2, 2025
Image Not Found

Can BD’s Expanded Recall of Alaris™ Pump Infusion Sets Trigger a Turning Point in Medical Device Safety Standards?

Key Insights BD’s updated recall follows internal testing that revealed infusion performance deviations, including flow rate accuracy issues,…

ByByAnuja SinghSep 13, 2025

Can Johnson & Johnson’s Pact with Pacira BioSciences Redefine Early Intervention for Knee Osteoarthritis?

Key Insights Expanding Non-Surgical Pathways Through this agreement, Johnson & Johnson MedTech integrates ZILRETTA® into its Early Intervention…

ByByAnuja SinghSep 13, 2025
Scroll to Top